2009 Press Releases
QLT Inc. Establishes Sales Force in the United States
QLT Restructures Visudyne® Agreement
June 15
QLT Announces 12-Month Results From Novartis Sponsored MONT BLANC Study Evaluating Standard-Fluence Visudyne® Combination Therapy
PDF version
June 02
QLT Announces Positive Results From the Evaluation of Visudyne® Combination Therapy
May 21
QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court
April 28
QLT Announces First Quarter Results for 2009
March 26
QLT Names Kathryn Falberg to the Board of Directors
March 12
QLT Announces Completion of Phase Ia Safety Trial of Its Synthetic Retinoid Product
February 24
QLT Petition For Rehearing of Massachusetts Eye and Ear Infirmary Litigation is Denied
February 19
QLT Announces Fourth Quarter and Year End 2008 Results
February 12
QLT Announces That It is Named as a Defendant in an Action
January 30
QLT Announces Final Results of Tender Offer
January 27
QLT Announces Preliminary Results of Tender Offer
January 15
QLT Announces New Expiration Date of Dutch Tender
January 12
QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation
QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2008